A french group has found preliminary evidence that PCR saliva testing is useful for the detection of herpesvirus reactivation among patients with drug hypersensitivity syndromes.
Successful use of Artesunate to treat HHV-6B myocarditis in a child
A group from Children’s Heart Centre in Lund, Sweden, has used Artesunate as an effective antiviral therapy to aid in the treatment of a child with HHV-6B myocarditis.
Encephalopathy Syndrome (PRES) reported in child with HHV-6B encephalitis
A group from Fujita Health University has identified the first known case of posterior reversible encephaliopathy syndrome (PRES) associated with HHV-6B encephalitis.
2013 International conference largest ever
A record number of researchers and clinicians gathered in Paris for the 8th International Conference on HHV-6 & 7
ciHHV-6 diagnostic test now available
A newly developed assay is now commercially available for clinical diagnosis of chromosomally integrated HHV-6 (ciHHV-6)
Dr. Yoshiki Kawamura receives first “Caroline B. Hall Young Investigator Award”
Dr. William Hall awards the first annual “Caroline B. Hall Young Investigator Award” to Dr. Yoshiki Kawamura of Japan.
Mothers with ciHHV-6 can produce active virus, transmit to children transplacentally
New findings suggest that ciHHV-6 can be reactivated and then acquired transplacentally.
NIH Laboratory develops novel marmoset model of HHV-6A & HHV-6B infection
Dr. Steven Jacobson’s laboratory at the US National Institute of Health has developed a novel marmoset model for the study of HHV-6 infection.
Role for HHV-6 in patients with renal failure?
A new study from Brazil indicates that active HHV-6 infection may play a role in patients with renal failure prior to transplantation.
New study shows that HHV-6 encephalitis leads to very poor outcome
New study shows that patients who develop HHV-6 encephalitis have a significantly poor prognosis
Herpesvirus foundation established in Zambia, studies HHV-6A & HHV-6B
Nonprofit dedicated to promoting herpesvirus research in Zambia and across sub-Saharan Africa.
Why does HHV-6 reactivate preferentially in CBT?
A group from France has reported new findings which may help explain the mystery behind the increased rates of HHV-6 reactivation and encephalitis observed among umbilical cord blood transplant (CBT) patients.
Bortezomib may increase risk of HHV-6 reactivation in myeloma patients
A new study has reported that the use of Bortezomib, known commercially as Velcade, may increase the risk of HHV-6 reactivation in myeloma patients undergoing stem cell transplantation.
Funding gap! HHV-6 & HHV-7 have received only a fraction of the funding received by EBV, CMV and HHV-8.
Since 2000, NIH has given nearly $1 Billion in total grant funding to study the herpesviruses EBV, CMV, and KSHV, compared to only $15 million to study HHV-6 & HHV-7.
Increased prevalence of HHV-6 antibodies discovered in multiple sclerosis patients
An increased prevalence of HHV-6 U94/REP antibodies found among Tunisian MS patients.